CTT-1057 Completed Phase 1 Trials for Prostate Cancer Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic1
clinicaltrials.gov IdentifierTitleDrugs
NCT02916537A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057